294 related articles for article (PubMed ID: 16510339)
1. Ocular involvement as first sign of isolated CNS relapse in diffuse large B-cell lymphoma.
Ferrari A; Luppi M; Lazzerini A; Potenza L; Cavallini GM; Torelli G
Lancet Oncol; 2006 Mar; 7(3):274. PubMed ID: 16510339
[No Abstract] [Full Text] [Related]
2. Aggressive lymphoma involving intracranial epidural region.
Villela LM; Blanco-Salazar A; Caballero R; Borbolla-Escoboza R
J Neurooncol; 2007 Jun; 83(2):181-2. PubMed ID: 17332949
[No Abstract] [Full Text] [Related]
3. Rituximab plus CHOP for diffuse large-B-cell lymphoma.
Akhtar S; Maghfoor I
N Engl J Med; 2002 Jun; 346(23):1830-1; author reply 1830-1. PubMed ID: 12050349
[No Abstract] [Full Text] [Related]
4. Diffuse large B-cell lymphoma with fibrillary matrix.
Dargent JL; Meiers I; Lespagnard L; Ma Y; Dehou MF; Verhest A
Diagn Cytopathol; 2002 Oct; 27(4):223-6. PubMed ID: 12357500
[TBL] [Abstract][Full Text] [Related]
5. Large gastrosplenic fistula after effective treatment of abdominal diffuse large-B-cell lymphoma.
Palmowski M; Zechmann C; Satzl S; Bartling S; Hallscheidt P
Ann Hematol; 2008 Apr; 87(4):337-8. PubMed ID: 17929016
[No Abstract] [Full Text] [Related]
6. A 61-year-old man with dyspepsia and weight loss.
Burton C
PLoS Med; 2005 Jun; 2(6):e154. PubMed ID: 15971937
[TBL] [Abstract][Full Text] [Related]
7. CD5+ T-cell/histiocyte-rich large B-cell lymphoma.
Chang CC; Bunyi-Teopengco E; Eshoa C; Chitambar CR; Kampalath B
Mod Pathol; 2002 Oct; 15(10):1051-7. PubMed ID: 12379751
[TBL] [Abstract][Full Text] [Related]
8. Non-Hodgkin's lymphoma and acquired immune deficiency syndrome (AIDS). A case report.
Plemons JM; Benton E; Rankin KV
Tex Dent J; 2005 Jul; 122(7):658-64. PubMed ID: 16152890
[No Abstract] [Full Text] [Related]
9. [Prognostic impact of bone marrow involvement (BMI) and therapies in diffuse large B cell lymphoma].
Yi SH; Xu Y; Zou DH; An G; Zhao YZ; Qi JY; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2009 May; 30(5):307-12. PubMed ID: 19799125
[TBL] [Abstract][Full Text] [Related]
10. CHOP and rituximab in elderly patients.
Portlock CS
Curr Oncol Rep; 2002 Sep; 4(5):414. PubMed ID: 12162916
[No Abstract] [Full Text] [Related]
11. [Non-Hodgkin lymphoma of the infratemporalis fossa: a case report].
Boulaich M; Oujilal A; Nazih N; Filali A; Lazrak A; Kzadri M
Rev Stomatol Chir Maxillofac; 2003 Dec; 104(6):347-51. PubMed ID: 14968099
[TBL] [Abstract][Full Text] [Related]
12. Long standing priapism as presentation of lymphoma.
Madeb R; Rub R; Erlich N; Hegarty PK; Yachia D
Am J Hematol; 2007 Jan; 82(1):87. PubMed ID: 17078020
[No Abstract] [Full Text] [Related]
13. Isolated central nervous system relapses in primary mediastinal large B-cell lymphoma after CHOP-like chemotherapy with or without Rituximab.
Papageorgiou SG; Diamantopoulos P; Levidou G; Angelopoulou MK; Economopoulou P; Efthimiou A; Constantinou N; Katsigiannis A; Korkolopoulou P; Pappa V; Economopoulou C; Georgiou G; Dimou M; Tsirigotis P; Kyrtsonis MC; Kotsianidis I; Kalpadakis C; Dimopoulos MA; Beris P; Meletis J; Pangalis GA; Dervenoulas J; Panayiotidis P; Vassilakopoulos TP
Hematol Oncol; 2013 Mar; 31(1):10-7. PubMed ID: 22610484
[TBL] [Abstract][Full Text] [Related]
14. Absolute lymphocyte counts predicts response to chemotherapy and survival in diffuse large B-cell lymphoma.
Kim DH; Baek JH; Chae YS; Kim YK; Kim HJ; Park YH; Song HS; Chung JS; Hyun MS; Sohn SK
Leukemia; 2007 Oct; 21(10):2227-30. PubMed ID: 17554383
[No Abstract] [Full Text] [Related]
15. ALK-positive diffuse large B-cell lymphoma: two more cases and a brief literature review.
Rudzki Z; Rucińska M; Jurczak W; Skotnicki AB; Maramorosz-Kurianowicz M; Mruk A; Piróg K; Utych G; Bodzioch P; Srebro-Stariczyk M; Włodarska I; Stachura J
Pol J Pathol; 2005; 56(1):37-45. PubMed ID: 15921012
[TBL] [Abstract][Full Text] [Related]
16. Standard treatment of advanced-stage diffuse large B-cell lymphoma.
Coiffier B
Semin Hematol; 2006 Oct; 43(4):213-20. PubMed ID: 17027655
[TBL] [Abstract][Full Text] [Related]
17. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
Fabbri A; Gozzetti A; Rigacci L
Cancer; 2011 Aug; 117(15):3530; author reply 3531. PubMed ID: 21287541
[No Abstract] [Full Text] [Related]
18. Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature.
Guirguis HR; Cheung MC; Mahrous M; Piliotis E; Berinstein N; Imrie KR; Zhang L; Buckstein R
Br J Haematol; 2012 Oct; 159(1):39-49. PubMed ID: 22849793
[TBL] [Abstract][Full Text] [Related]
19. Cost utility in the United States of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone for the treatment of elderly patients with diffuse large B-cell lymphoma.
Hornberger JC; Best JH
Cancer; 2005 Apr; 103(8):1644-51. PubMed ID: 15756658
[TBL] [Abstract][Full Text] [Related]
20. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia.
Sehn LH; Donaldson J; Chhanabhai M; Fitzgerald C; Gill K; Klasa R; MacPherson N; O'Reilly S; Spinelli JJ; Sutherland J; Wilson KS; Gascoyne RD; Connors JM
J Clin Oncol; 2005 Aug; 23(22):5027-33. PubMed ID: 15955905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
